Erlotinib (commonly sold under the brand name Tarceva) is a prescription, oral anti-cancer medication used to treat metastatic non-small cell lung cancer (NSCLC) with specific EGFR mutations and advanced pancreatic cancer in combination with gemcitabine. It acts as an EGFR inhibitor, typically taken daily on an empty stomach to block cancer growth.